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Synopsis
Summary of Manente G,Torrieri F, Di Blasio F, Staniscia
T, Romano F and Uncini A (2001): An innovative hand
brace for carpal tunnel syndrome: a randomised
controlled trial. Muscle and Nerve 24: 1020-1025.
[Prepared by Karen Grimmer, Editorial Board member.]
Question: Does a novel hand brace improve symptoms
and function in patients with carpal tunnel syndrome?
Study design: Randomised, controlled clinical trial using
concealed allocation. Setting: A hospital neurology clinic in
Italy. Patients: Of 151 patients referred for possible carpal
tunnel syndrome to the clinic, 83 met the following inclusion
criteria and were recruited: predominantly one hand with
carpal tunnel symptoms (pain, numbness, paresthesia in
median nerve distribution) and signs (hypesthesia in
median nerve distribution, thenar atrophy, positive Phalen
test); and at least one abnormal median nerve
electrophysiological study. Exclusion criteria included:
history of previous carpal tunnel surgery; rheumatoid
arthritis; carpal tunnel syndrome related to systemic
diseases; pregnancy; and clinical and electrophysiological
signs of polyneuropathy. Main outcome measure: Boston
Carpal Tunnel Questionnaire yielding separate symptom
severity and functional limitation scores ranging from 1
(best) to 5 (worst). Secondary outcomes included subjects’
opinion of recovery (“moderate improvement”, “minimal
improvement”, “no change” and “worse”) and EMG
measures. Intervention: All subjects agreed not to
commence any other treatment during the intervention
period (4 weeks) nor to change their usual activities. The
intervention group (n = 41) wore a hand brace at night for
four weeks. The brace (Manubrace) consists of 1) a palmar
strap with Velcro fastening to tighten the distal heads of 2nd
and 5th metacarpal bones; 2) a triangular pad positioned
dorsal to digits 2 and 5; 3) a dorsal strap connected by
adjustable Velcro fasteners to a wrist band; and 4) a
stabilisation component for the other aspects of hand and
wrist. Compliance was high, with 38 subjects wearing the
brace on all or most nights. The control group (n = 42) had
no treatment. Results: Groups were comparable at
baseline and only three patients were lost to follow-up (one
intervention and two controls). At both 2 and 4 weeks follow-
up, the brace group had fewer symptoms and functional
limitation than the control group (all 
p < 0.001). For example, at 4 weeks the mean (SD) for
symptoms was 1.54 (0.4) in the brace group v. 2.61 (0.6) in
the control group and for functional limitation 1.48 (0.5) in
the brace and 2.03 (0.7) in the control group. The brace
group reported greater recovery than the control group 
(p = 0.006). For example 40/40 braced patients reported
improvement v. 10/40 controls. There were no between-
group differences in EMG measurements. Conclusion:
When consistently worn at night, the Manu hand brace
significantly reduced symptoms and functional loss in
patients with carpal tunnel syndrome.
Commentary
The anatomic rationale proposed for the Manu splint
includes changes to the shape of the carpal tunnel and
reduction in the presence of the lumbricals in the tunnel.
Given our understanding of carpal tunnel syndrome, these
are plausible mechanisms. As well, because the
methodology used in this study is strong, we can have
confidence in the authors’ conclusion that the hand brace
significantly reduced symptoms and functional loss in
patients with carpal tunnel syndrome. However, it has been
my experience that patients can report improvement, not
cure, with conservative treatment and thus still require
surgery. It is important to the understanding of the
management of carpal tunnel syndrome to distinguish
between improvement and cure. How many patients
required further treatment or surgery? Longer term follow-
up in this trial could have provided this important
information.  
Given the high prevalence and associated costs of carpal
tunnel syndrome, new treatment options, like this splint
design, should be a priority for physiotherapy research.
This clinical trial established that the splint was more
effective than no treatment, however we already know that
night splinting of the wrist at neutral is effective in
minimising carpal tunnel symptoms (Burke et al 1994).
Clinical therapists should consider this splint promising,
but experimental. Before embracing this new splint design
we need to compare its effectiveness with that of existing
splints. We also need to investigate the optimal application
of splints, as wear time influences success (Walker et al
2000). Furthermore, as there are a number of other
physiotherapy treatments that can be used as adjuncts in the
treatment of CTS, the role of this new splint in a
comprehensive physiotherapy program should also be
considered. 
Joy MacDermid
St Josephs Health Centre, Canada
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